CI Investments Inc’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.94M | Buy |
53,963
+46,250
| +600% | +$1.67M | 0.01% | 364 |
|
|
2025
Q1 | $240K | Sell |
7,713
-3,918
| -34% | -$122K | ﹤0.01% | 671 |
|
|
2024
Q4 | $297K | Buy |
11,631
+1,616
| +16% | +$41.3K | ﹤0.01% | 625 |
|
|
2024
Q3 | $283K | Sell |
10,015
-36
| -0.4% | -$1.02K | ﹤0.01% | 580 |
|
|
2024
Q2 | $265K | Sell |
10,051
-1,482
| -13% | -$39.1K | ﹤0.01% | 573 |
|
|
2024
Q1 | $350K | Buy |
11,533
+5,264
| +84% | +$160K | ﹤0.01% | 549 |
|
|
2023
Q4 | $176K | Sell |
6,269
-1,041
| -14% | -$29.2K | ﹤0.01% | 694 |
|
|
2023
Q3 | $198K | Sell |
7,310
-957
| -12% | -$25.9K | ﹤0.01% | 632 |
|
|
2023
Q2 | $254K | Buy |
8,267
+4,007
| +94% | +$123K | ﹤0.01% | 594 |
|
|
2023
Q1 | $153K | Buy |
4,260
+2,690
| +171% | +$96.6K | ﹤0.01% | 643 |
|
|
2022
Q4 | $62K | Buy |
1,570
+605
| +63% | +$23.9K | ﹤0.01% | 869 |
|
|
2022
Q3 | $39K | Buy |
965
+427
| +79% | +$17.3K | ﹤0.01% | 878 |
|
|
2022
Q2 | $23K | Sell |
538
-1,148
| -68% | -$49.1K | ﹤0.01% | 956 |
|
|
2022
Q1 | $66K | Sell |
1,686
-222
| -12% | -$8.69K | ﹤0.01% | 922 |
|
|
2021
Q4 | $76K | Buy |
1,908
+512
| +37% | +$20.4K | ﹤0.01% | 950 |
|
|
2021
Q3 | $50K | Buy |
+1,396
| New | +$50K | ﹤0.01% | 967 |
|